Ruprecht-Karls-Universität Heidelberg

Creating a measure to operationalize engaged well-being at work (2021) Bosle C, Fischer JE, Herr RM Journal article Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis (2021) Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M Journal article, Review article Comparison of different symmetry indices for the quantification of dynamic joint angles (2021) Siebers HL, Alrawashdeh W, Betsch M, Migliorini F, Hildebrand F, Eschweiler J Journal article An Evolutionary Perspective on Hox Binding Site Preferences in Two Different Tissues (2021) Folkendt L, Lohmann I, Domsch K Journal article Different Prevalence of Alarm, Dyspeptic and Reflux Symptoms in Patients with Cardia and Non-cardia Gastric Cancer (2021) Franck C, Zimmermann N, Goni E, Lippert H, Ridwelski K, Kruschewski M, Kreuser N, et al. Journal article HESS Follow-up Observations of Binary Black Hole Coalescence Events during the Second and Third Gravitational-wave Observing Runs of Advanced LIGO and Advanced Virgo (2021) Abdalla H, Aharonian F, Benkhali FA, Anguner EO, Ashkar H, Backes M, Baghmanyan , et al. Journal article Prenatal Androgen Influence on Addictive Behaviour in Adolescence Vorgeburtlicher Androgen- einfluss auf süchtiges Verhalten in der Adoleszenz (2021) Lenz B, Eichler A, Buchholz VN, Fasching P, Kornhuber J Journal article, Review article Comparative physical activity as a global question to assess physical activity among university students (2021) Diehl K, Brassat A, Hilger-Kolb J Journal article Correction to: Innovative radiation oncology Together—Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany (Strahlentherapie und Onkologie, (2021), 197, 12, (1043-1048), 10.1007/s00066-021-01843-9) (2021) Krug D, Hecht M, Ebert N, Maurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article, Erratum Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021) Jaramillo S, Krisam J, Le Cornet L, Kratzmann M, Baumann L, Sauer T, Crysandt M, et al. Journal article